Jump to content

Main menu Navigation ●Main page ●Contents ●Current events ●Random article ●About Wikipedia ●Contact us ●Donate Contribute ●Help ●Learn to edit ●Community portal ●Recent changes ●Upload file

Search

●Create account ●Log in ●Create account ● Log in Pages for logged out editors learn more ●Contributions ●Talk

Contents

(Top) 1 See also 2 References

Rimiterol

●العربية ●فارسی ●Italiano ●Polski ●Српски / srpski ●Srpskohrvatski / српскохрватски ●中文 Edit links ●Article ●Talk ●Read ●Edit ●View history Tools Actions ●Read ●Edit ●View history General ●What links here ●Related changes ●Upload file ●Special pages ●Permanent link ●Page information ●Cite this page ●Get shortened URL ●Download QR code ●Wikidata item Print/export ●Download as PDF ●Printable version In other projects ●Wikimedia Commons Appearance From Wikipedia, the free encyclopedia

Rimiterol

Clinical data

Pregnancy
category

AU:A

R03AC05 (WHO)

Legal status

AU: S4 (Prescription only)

Identifiers

4-{(S)-hydroxy[(2R)-piperidin-2-yl]methyl}benzene-1,2-diol

32953-89-2^N

36283

33366^Y

26GIW6ZLPH

ChEMBL1097630^N

CompTox Dashboard (EPA)

DTXSID70186603

Chemical and physical data

C₁₂H₁₇NO₃

223.272 g·mol⁻¹

3D model (JSmol)

Interactive image

O[C@@H](c1ccc(O)c(O)c1)[C@@H]2NCCCC2

InChI=1S/C12H17NO3/c14-10-5-4-8(7-11(10)15)12(16)9-3-1-2-6-13-9/h4-5,7,9,12-16H,1-3,6H2/t9-,12+/m1/s1^Y

Key:IYMMESGOJVNCKV-SKDRFNHKSA-N^Y

^NY (what is this?) (verify)

Rimiterol (INN/USAN) is a third-generation^[1] short-acting^[2]^[3] β₂ agonist.

See also[edit]

References[edit]

^ Palma-Carlos AG, Palma-Carlos GS (April 1986). "Beta-2-agonists of third generation". Allergie et Immunologie. 18 (4): 31–2, 35. PMID 2899434.

^ Lai CK, Twentyman OP, Holgate ST (October 1989). "The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness". The American Review of Respiratory Disease. 140 (4): 917–23. doi:10.1164/ajrccm/140.4.917. PMID 2572192.

^ Ydreborg SO, Svedmyr N, Thiringer G (April 1977). "Comparison of rimiterol and terbutaline, given by aerosol, in a long-term study". Scandinavian Journal of Respiratory Diseases. 58 (2): 117–24. PMID 16339.

Drugs for obstructive airway diseases: asthma/COPD (R03)

Adrenergics, inhalants

Short-acting β₂ agonists

Bitolterol

Salbutamol (albuterol)^#/Levosalbutamol (levalbuterol)

Long-acting β₂ agonists

Bambuterol

Formoterol/Arformoterol

Ultra-long-acting β₂ agonists

Abediterol

Other

Epinephrine^#

Isoprenaline (isoproterenol)

Orciprenaline (metaproterenol)

Glucocorticoids

Beclometasone^#

Betamethasone^#

Fluticasone propionate

Anticholinergics/
muscarinic antagonist

Aclidinium bromide

Glycopyrronium bromide

Ipratropium bromide^#

Oxitropium bromide

Tiotropium bromide

Umeclidinium bromide

Mast cell stabilizers

Cromoglicate

Acefylline

Choline theophyllinate

Eicosanoid inhibition

Leukotriene antagonists

Montelukast

Arachidonate 5-lipoxygenase inhibitors

Zileuton

Thromboxane receptor antagonists

Ramatroban

Non-xanthine PDE4 inhibitors

Ibudilast

Others/unknown

Amlexanox

Combination products

Aclidinium bromide/formoterol

Beclometasone/formoterol

Beclometasone/formoterol/glycopyrronium bromide

Budesonide/formoterol

Budesonide/glycopyrronium bromide/formoterol

Fluticasone furoate/umeclidinium bromide/vilanterol

Fluticasone furoate/vilanterol

Fluticasone propionate/salmeterol

Glycopyrronium bromide/formoterol

Indacaterol/glycopyrronium bromide

Indacaterol/glycopyrronium bromide/mometasone

Indacaterol/mometasone

Ipratropium bromide/salbutamol

Mometasone/formoterol

Salbutamol (albuterol)/budesonide

Umeclidinium bromide/vilanterol

^#WHO-EM

^‡Withdrawn from market

Clinical trials:

^†Phase III

^§Never to phase III

Adrenergic receptor modulators

Agonists

6-FNE

Deoxyepinephrine (epinine, N-methyldopamine)

Desglymidodrine

Dexisometheptene

Droxidopa (L-DOPS)

Ethylnorepinephrine

L-DOPA (levodopa)

L-Phenylalanine

Phenylpropanolamine

Antagonists

Abanoquil

Atypical antipsychotics (e.g., brexpiprazole, clozapine, olanzapine, quetiapine, risperidone)

Beta blockers (e.g., adimolol, amosulalol, arotinolol, carvedilol, eugenodilol, labetalol)

Ergolines (e.g., acetergamine, ergotamine, dihydroergotamine, lisuride, nicergoline, terguride)

Phenoxybenzamine

Phenylpiperazine antidepressants (e.g., hydroxynefazodone, nefazodone, trazodone, triazoledione)

Tetracyclic antidepressants (e.g., amoxapine, maprotiline, mianserin)

Tricyclic antidepressants (e.g., amitriptyline, clomipramine, doxepin, imipramine, trimipramine)

Typical antipsychotics (e.g., chlorpromazine, fluphenazine, loxapine, thioridazine)

Agonists

(R)-3-Nitrobiphenyline

Deoxyepinephrine (epinine, N-methyldopamine)

Dexmedetomidine

Dihydroergotamine

Droxidopa (L-DOPS)

Ethylnorepinephrine

L-DOPA (levodopa)

L-Phenylalanine

Phenylpropanolamine

Antagonists

1-PP

Atypical antipsychotics (e.g., asenapine, brexpiprazole, clozapine, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, zotepine)

Azapirones (e.g., buspirone, gepirone, ipsapirone, tandospirone)

Phenoxybenzamine

Typical antipsychotics (e.g., chlorpromazine, fluphenazine, loxapine, thioridazine)

Agonists

Abediterol

Deoxyepinephrine (epinine, N-methyldopamine)

Droxidopa (L-DOPS)

Ethylnorepinephrine

L-DOPA (levodopa)

L-Phenylalanine

Methoxyphenamine

Phenylpropanolamine

Antagonists

Acebutolol

Dichloroisoprenaline

Dihydroalprenolol

Hydroxycarteolol

Hydroxytertatolol

Iodocyanopindolol

See also: Receptor/signaling modulators

Dopaminergics

Serotonergics

Monoamine reuptake inhibitors

Monoamine releasing agents

Monoamine metabolism modulators

Monoamine neurotoxins

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

t

e

Retrieved from "https://en.wikipedia.org/w/index.php?title=Rimiterol&oldid=1129943449" Categories: ●2-Benzylpiperidines ●Beta-adrenergic agonists ●Catecholamines ●Phenylethanolamines ●2-Piperidinyl compounds ●Respiratory system drug stubs Hidden categories: ●Articles with short description ●Short description matches Wikidata ●Articles with changed CASNo identifier ●Articles with changed EBI identifier ●ECHA InfoCard ID from Wikidata ●Chemical pages without DrugBank identifier ●Articles without KEGG source ●Drugboxes which contain changes to verified fields ●All stub articles ●This page was last edited on 27 December 2022, at 21:42 (UTC). ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization. ●Privacy policy ●About Wikipedia ●Disclaimers ●Contact Wikipedia ●Code of Conduct ●Developers ●Statistics ●Cookie statement ●Mobile view